EVH - Evolent Health Inc. (EVH) Q4 2023 Earnings Call Transcript
2024-02-22 22:34:06 ET
Evolent Health, Inc. (EVH)
Q4 2023 Earnings Conference Call
February 22, 2024 05:00 PM ET
Company Participants
Seth Frank - Vice President of Investor Relations
Seth Blackley - Chief Executive Officer, Co-Founder and Board Member
John Johnson - Chief Financial Officer
Conference Call Participants
Andrea Alfonso - UBS
Jailendra Singh - Truist Securities
Jeff Garro - Stephens
Anna Kruszenski - Barclays
Ryan Daniels - William Blair
Kyle Aikman - JPMorgan
Jessica Tassan - Piper Sandler
Charles Rhyee - TD Cowen
Richard Close - Canaccord Genuity
Jenny Shen - BTIG
Tommy Schuyler - RBC Capital Markets
Jack Wallace - Guggenheim Securities
Presentation
Operator
Welcome to the Evolent Earnings Conference Call for the Quarter and Year-Ended December 31, 2023. As a reminder, this conference call is being recorded. Host for the call today from Evolent are Seth Blackley, Chief Executive Officer; and John Johnson, Chief Financial Officer. The call will be archived and available later this evening and for next week via the webcast on the company's website in the section titled Investor Relations.
I'll now hand the call over to Seth Frank, Evolent's Vice President of Investor Relations.
Seth Frank
Thank you, and good evening. This conference call will contain forward-looking statements under the U.S. Federal laws. These statements are subject to risks and uncertainties that could cause actual results to differ materially from historical experience or present expectations. A description of some of the risks and uncertainties can be found in the company's reports filed with the Securities and Exchange Commission, including cautionary statements included in our current and periodic filings. For additional information on the company's results and outlook, please refer to our fourth quarter press release issued earlier today.
Finally, as a reminder, reconciliations of non-GAAP measures discussed during today's call to the most direct comparable GAAP measures are available in the summary presentation available in the Investor Relations section of our website or in the company's press release issued today and posted on the Investor Relations section of the company's website ir.evolenthealth.com and the Form 8-K filed by the company with the SEC earlier today.
And now, I'll turn the call over to Evolent's CEO, Seth Blackley.
Seth Blackley
Good evening, and thanks for joining us. I'm excited to share with you our results for the fourth quarter and the full-year 2023. We had another outstanding year achieving our profitability, cash flow, new business growth and operating goals for all of our stakeholders, and we remain focused on our mission of improving care for people with complex conditions....
Evolent Health, Inc. (EVH) Q4 2023 Earnings Call Transcript